Acceleration of reverse cholesterol transport

Current Opinion in Cardiology

Volumn 15, Issue 5, 2000, Pages 348-354

  Von Eckardstein, A ^a   Nofer, J R ^a   Assmann, G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL TRANSPORT; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

APOLIPOPROTEINS E; ARTERIOSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; CHOLESTEROL, HDL; HUMANS; MUTATION; PROTEIN TRANSPORT;

EID: 0033816973     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200009000-00007     Document Type: Review

References (80)

1. Current concepts: High density lipoproteins - The clinical implications of recent studies
2. Genes influencing HDL metabolism: New perspectives and implications for atherosclerosis prevention
3. Atheroprotective mechanisms of HDL
4. High density lipoproteins in health and disease
5. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species including humans
6. Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals
7. Relation between baseline and on treatment parameters and first acute major coronary events in the Air Force/Texas coronary atheroscelrosis prevention study (AFCAPS/TexCAPS)
8. Coronary heart disease: Reducing the risk. A worldwide view
9. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high density lipoprotein cholesterol
10. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The bezafibrate infarction prevention (BIP) study
11. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
12. Physiological role and clinical relevance of high-density lipoprotein subclasses
13. Pre- β HDL: Structure and metabolism
14. A solely apolipoprotein E containing plasma lipoprotein with electrophoretic gamma-mobility takes up cellular cholesterol
15. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma
16. Remodelling of high density lipoproteins by plasma factors
17. Apolipoprotein-mediated cellular cholesterol efflux
18. High density lipoprotein receptors, binding proteins, and ligands
19. Charting the fate of the good cholesterol: Identification and characterization of the high density lipoprotein receptor SR-B1
20. The role of high-density lipoprotein receptor SR-B1 in cholesterol metabolism
21. Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptors B1
22. A novel endothelial-derived lipase that modulates HDL metabolism
23. Cloning of unique lipase from endothelial cells extends the lipase gene family
24. Cholesterol efflux from macrophages and other cells
25. Cell cholesterol efflux: Integration of old and new observations provides new insights
26. Apolipoprotein-mediated plasma membrane microsolubilization: Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid
27. Cholesterol efflux to apolipoprotein A-I involves endocytosis and resecretion in a calcium-dependent pathway
28. Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation
29. Intracellular cholesterol transport in synchronized human skin fibroblasts
30. Apolipoprotein A-I efficiently binds to and mediates cholesterol and phospholipid efflux from human but not from rat aortic smooth muscle cells
31. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease
32. Decreased reverse cholesterol transport from Tangier disease fibroblasts: Acceptor specificity and effect of brefeldin on lipid efflux
33. Intracellular cholesterol transport
34. Induction of cholesterol efflux to lipid-free apolipoprotein A-I by cAMP
35. Scavenger receptor B1 mediates free cholesterol flux independent of HDL tethering to the cell surface
36. Familial high density lipoprotein deficiency: Tangier disease
37. Mutations in ABC1 in Tangier disease and familial high density lipoprotein deficiency
38. The gene encoding ATP binding cassette transporter 1 is mutated in Tangier disease
39. Tangier disease is caused by mutations in the gene encoding ATP binding cassette transporter 1
40. Human ATP binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred
41. The Tangier disease gene product controls the cellular apolipoprotein-mediated lipid removal pathway
42. ABCG1 (ABC8), the human homolog of the Drosophila white gene is a regulator of macrophage cholesterol and phospholipid transport
43. The ABC-A subclass of mammalian transporters
44. Molecular cloning of the human ATP binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
45. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes
46. Interleukin 1β secretion is impaired by inhibitors of the ATP binding cassette transporter ABC1
47. Lipid translocation accross the plasma membrane of mammalian cells
48. Analysis of hABC1 gene 5' end: Additional peptide sequence, promoter region, and four polymorphisms
49. Human White/Murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols
50. Tangier disease: A disorder of intracellular membrane traffic
51. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease. Patients and Abc1-deficient mice
52. Intracellular CFTR: Localization and function
53. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice
54. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cessette transporter-1
55. Apolipoprotein E and atherosclerosis
56. Macrophages, lipoprotein metabolism, and atherosclerosis: Insights from murine bone marrow transplantation studies
57. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage like foam cells
58. Apolipoprotein A-I stimulates secretion of apolipoprotein E by foam cell macrophages
59. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors
60. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors
61. Phenotype-dependent differences in apolipoprotein E metabolism and cholesterol homeostasis in human monocyte-derived macrophages
62. Apolipoprotein E-dependent cholesterol efflux from macrophages: Kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E
63. 3 and lipid, free apolipoproteins in mouse peritoneal macrophages
64. Familial HDL deficiency syndromes
65. The molecular parhology of lecithin: Cholesterol acyltransferase (LCAT) deficiency syndromes
66. Hepatic lipase deficiency
67. Hepatic lipase: New insights from genetic and metabolic studies
68. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
69. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia
70. Transgenic animals with altered high density lipoprotein composition and functions
71. Apolipoprotein A-IV plasma concentrations and coronary artery disease
72. Low-dose expression of a human apolipoprotein E transgene in macrophages restores defective cholesterol efflux capacity of apolipoprotein E deficient mouse plasma
73. Reverse cholesterol transport in plasma of patients with different forms of familial high density lipoprotein deficiency
74. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high density lipoproteins
75. 1-HDL
76. Proteolytic degradation of preβ1-LpA-l by rat mast cell chymase reduces high affinity efflux of cholesterol from macrophage foam cells in vitro
77. Matrix metalloproteinases-3,-7, and -12 but not -9 reduce high density lipoprotein induced cholesterol efflux from human macrophage foam cells by truncation of the carboxylterminus of apolipoprotein A-I. Parallel losses of pre-particels and the high affinity component of efflux
78. Increased pre- β-HDL levels, cholesterol efflux, and LCAT mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes
79. Increased pre- β-high density lipoprotein aplipoprotein A-I and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein A-I transgenes
80. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice